Antimutagenic activity of a secoisopimarane diterpenoid from Salvia cinnabarina M. Martens et Galeotti in the bacterial reverse mutation assay

Food and Chemical Toxicology

Volumn 47, Issue 8, 2009, Pages 2092-2096

  Di Sotto, A ^a   Mastrangelo, S ^a   Romussi, G ^b   Bisio, A ^b   Mazzanti, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

3,4 Secoisopimar 4(18),7,15 trien 3 oic acid; Ames test; Antimutagenicity; Diterpenoid; Salvia cinnabarina

Indexed keywords

2 AMINOANTHRACENE; 2 NITROFLUORENE; 3,4 SECOISOPIMAR 4(18),7,15 TRIEN 3 OIC ACID; ANTIMUTAGENIC AGENT; DITERPENOID; MESYLIC ACID DERIVATIVE; MUTAGENIC AGENT; PLANT EXTRACT; SALVIA CINNABARINA EXTRACT; SODIUM AZIDE; UNCLASSIFIED DRUG;

AMES TEST; ANTIMUTAGENIC ACTIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ESCHERICHIA COLI; MICROBIOLOGY; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM; SALVIA; SALVIA CINNABARINA;

ANIMALS; ANTIMUTAGENIC AGENTS; BACTERIA; CELL SURVIVAL; CULTURE MEDIA; CYTOCHROME P-450 ENZYME SYSTEM; DITERPENES; MUTAGENICITY TESTS; RATS; SALVIA; SOLUBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SALMONELLA TYPHIMURIUM; SALVIA CINNABARINA;

EID: 68749090792     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.05.030     Document Type: Article

References (41)

1. Alfieri A., Maione F., Bisio A., Romussi G., Mascolo N., and Cicala C. Effect of a diterpenoid from Salvia cinnabarina on arterial blood pressure in rats. Phytother. Res. 21 (2007) 690-692
2. Ames B.N., Mc Cann J., and Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31 (1975) 347-364
3. Barnes J., Anderson L.A., and Phillipson J.D. Sage. In: RPS (Ed). Herbal Medicines. third ed. (2007), Pharmaceutical Press, London, UK 512-514
4. Bisio A., Pagano B., Romussi A., Bruno O., De Tommasi N., Romussi G., and Mattia C.A. Relative stereochemistry of a diterpene from Salvia cinnabarina. Molecules 12 (2007) 2279-2287
5. Brusick D.J., Simmon V.F., Rosenkranz H.S., Ray V.A., and Stafford R.S. An evaluation of the Escherichia coli WP2 and WP2 uvrA reverse mutation assay. Mutat. Res. 76 (1980) 169-190
6. Capasso R., Izzo A.A., Capasso F., Romussi G., Bisio A., and Mascolo N. Diterpenoid from Salvia cinnabarina inhibits mouse intestinal motility in vivo. Planta Med. 70 (2004) 375-377
7. Capasso R.A., Izzo A., Romussi G., Capasso F., De Tommasi N., Bisio A., and Mascolo N. A secoisopimarane diterpenoid from Salvia cinnabarina inhibits rat urinary bladder contractility in vitro. Planta Med. 70 (2004) 185-188
8. Cavin C., Holzhaeuser D., Scharf G., Constable A., Huber W.W., and Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem. Toxicol. 40 (2002) 1155-1163
9. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402 (1998) 151-158
10. De Flora S., Bennicelli C., D'Agostmim F., Izzotti A., and Camoirano A. Cytosolic activation of aromatic and heterocyclic amines. Environ. Health Perspect. 102 (1994) 69-74
11. Del Baño M.J., Castillo J., Benavente-García O., Morente J., Martín-Gil R., Acevedo C., and Alcaraz M. Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by gamma-rays. J. Agri. Food Chem. 54 (2006) 2064-2068
12. DeMarini D.M. Influence of DNA repair on mutation spectra in Salmonella. Mutat. Res. 450 (2000) 5-17
13. Dimas K., Demetzos C., Vaos V., Ioannidis P., and Trangas T. Labdane type diterpenes down-regulate the expression of c-Myc protein, but not of Bcl-2, in human leukemia T-cells undergoing apoptosis. Leuk. Res. 25 (2001) 449-454
14. Dimas K., Kokkinopoulos D., Demetzos C., Vaos B., Marselos M., Malamas M., and Tzavaras T. The effect of sclareol on growth and cell cycle progression of human leukemic cell lines. Leuk. Res. 23 (1999) 217-234
15. Dimas K., Papadaki M., Tsimplouli C., Hatziantoniou S., Alevizopoulos K., Pantazis P., and Demetzos C. Labd-14-ene-8, 13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs. Biomed. Pharmacother. 60 (2006) 127-133
16. Edenharder R., and Tang X. Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluoranthene and 1-nitropyrene by flavonoids, coumarins, quinones and other phenolic compounds. Food Chem. Toxicol. 35 (1997) 357-372
17. Epling, C.A, 1939. Revision of Salvia, subgenus Calosphace. In: F. Fedde (Ed.), Repertorium Specierum Novarum regni Vegetabili, vol. CX, Berlin-Dahlem, Germany, p. 139.
18. Green M.H., and Muriel W.J. Mutagen testing using TRP+ reversion in Escherichia coli. Mutat. Res. 38 (1976) 3-32
19. Hatziantoniou S., Dimas K., Georgopoulos A., Sotiriadou N., and Demetzos C. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol. Res. 53 (2006) 80-87
20. Horn R.C., and Vargas V.M. Antimutagenic activity of extracts of natural substances in the Salmonella/microsome assay. Mutagenesis 18 (2003) 113-118
21. Huang S.C., Ho C.T., Lin-Shiau S.Y., and Lin J.K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through downregulating nuclear factor-kB and c-Jun. Biochem. Pharmacol. 69 (2005) 221-232
22. Jemnitz K., Veres Z., Torok G., Toth E., and Vereczkey L. Comparative study in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction. Mutagenesis 19 (2004) 245-250
23. Johnson J.J., Syed D.N., Heren C.R., Suh Y., Adhami V.M., and Mukhtar H. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway. Pharm. Res. 25 (2008) 2125-2134
24. Levin D.E., and Ames B.N. Classifying mutagens as to their specificity in causing the six possible transitions and transversions: a simple analysis using the Salmonella mutagenicity assay. Environ. Mutagen. 8 (1986) 9-28
25. Lindahl T., and Wood R.D. Quality control by DNA repair. Science 286 (1999) 1897-1905
26. Majer B.J., Hofer E., Cavin C., Lhoste E., Uhl M., Glatt H.R., Meinl W., and Knasmüller S. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem. Toxicol. 43 (2005) 433-441
27. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
28. Minnunni M., Wolleb U., Mueller O., Pfeifer A., and Aeschbacher H.U. Natural antioxidants as inhibitors of oxygen species induced mutagenicity. Mutat. Res. 269 (1992) 193-200
29. Negi P.S., Jayaprakasha G.K., and Jena B.S. Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chem. 80 (2003) 393-397
30. OECD (Organisation for Economic Cooperation and Development), 1997. Guideline for the testing of chemicals: bacteria reverse mutation test. Guideline 471.
31. Ohta T., Tokishita S., Tsunoi R., Ohmae S., and Yamagata H. Characterization of Trp(+) reversions in Escherichia coli strain WP2uvrA. Mutagenesis 17 (2002) 313-316
32. Olsen O., Wang X., and Von Wettstein D. Sodium azide mutagenesis: preferential generation of AT → GC transitions in the barley Antl8 gene. Proc. Natl. Acad. Sci. USA 90 (1993) 8043-8047
33. Pelroy R.A., and Gandolfi A.J. Use of mixed-function amine oxidase for metabolic activation in the Ames) Salmonella assay systems. Mutat. Res. 72 (1980) 329-334
34. Rau O., Wurglics M., Paulke A., Zitzkowski J., Meindl N., Bock A., Dingermann T., Abdel-Tawab M., and Schubert-Zsilavecz M. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med. 72 (2006) 881-887
35. Romussi G., Ciarallo G., Bisio A., Fontana N., De Simone F., De Tommasi N., Mascolo N., and Pinto L. A new diterpenoid with antispasmodic activity from Salvia cinnabarina. Planta Med. 67 (2001) 153-155
36. Rosenkranz H.S., and Mermelstein R. Mutagenicity and genotoxicity of nitroarenes. Mutat. Res. 114 (1983) 217-267
37. Shabtay A., Sharabani H., Barvish Z., Kafka M., Amichay D., Levy J., Sharoni Y., Uskokovic M.R., Studzinski G.P., and Danilenko M. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology 75 (2008) 203-214
38. Shamon, L.A., Pezzato, J.M., 1994. Plant antimutagens: a review and strategy for the identification of therapeutically useful agents. In: Wagne, H., Farnsworth, N.R. (Eds.), Economics and Medicinal Plant Research, vol. 6, first ed. Academic Press Harcourt Brace and Company, London, UK, pp. 235-297.
39. Tao K.S., Wang W., Wang L., Cao D.Y., Li Y.Q., Wu S.X., and Dou K.F. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med. Hypotheses 71 (2008) 730-736
40. Walker G.C. Mutagenesis-enhancement by plasmids in mutagenesis tester strains. Basic Life Sci. 34 (1984) 111-120
41. Wilcox P., Naidoo A., Wedd D.J., and Gatehouse D.G. Comparison of Salmonella typhimurium TA102 with Escherichia coli WP2 tester strains. Mutagenesis 5 (1990) 285-291